QI Path provides an adaptive risk intelligence platform leveraging AI and machine learning to analyze data and identify emerging risks for life sciences organizations. The platform synthesizes real-time insights with historical trends to enable proactive risk mitigation and accelerate data-informed decision-making. This results in measurable operational improvements, reduced quality issues, and enhanced regulatory compliance across clinical and operational processes.
Funding
Funding not disclosed
Founders
Product
Problem
Life sciences organizations face significant challenges in proactively identifying and mitigating risks within complex GxP processes, clinical trials, and manufacturing operations. Traditional risk management approaches are often reactive, time-consuming, and struggle to synthesize diverse data sources, leading to costly failures, compliance gaps, and operational inefficiencies.
Solution
QI Path provides an AI-driven adaptive risk intelligence platform designed to enable proactive error reduction and quality improvement in the life sciences sector. The platform synthesizes real-time data, historical trends, and frontline insights using machine learning to identify and mitigate risks before they impact operations. This approach facilitates data-informed decision-making, accelerates risk assessment workflows from months to minutes, and drives continuous process improvement. By integrating proven systems improvement methodologies with intelligent automation, QI Path empowers organizations to prevent costly failures, reduce CAPAs, and enhance operational excellence.
Target Audience
QI Path serves pharmaceutical and biotech companies, Contract Research Organizations (CROs), drug manufacturers, health systems, academic medical centers, and government agencies involved in life sciences and healthcare operations.
Features
- AI and machine learning algorithms for synthesizing large datasets and identifying hidden risks.
- Real-time data integration with historical trends and frontline perspectives for comprehensive risk analysis.
- Automated risk assessment and prioritization based on severity, likelihood, and strategic alignment.
- AI-assisted, process-based risk analysis to develop actionable mitigation strategies.
- Compliance alignment with ICH E6(R2/R3), ICH Q9, and Quality by Design (QbD) principles.
- Capabilities for reducing CAPAs, deviations, and regulatory risk across clinical and manufacturing operations.
- Tools to improve patient safety, clinical quality, and operational reliability in healthcare settings.
- Features for managing risk in public health, disaster preparedness, and military readiness scenarios.
- A flexible, structured framework for sustainable quality improvement.